targeted synthetic DMARD class — Competitive Intelligence Brief

targeted synthetic DMARD class (targeted synthetic DMARD class) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Targeted synthetic DMARD. Area: Immunology.

phase 3 Targeted synthetic DMARD Unknown Immunology Small molecule

Target snapshot

targeted synthetic DMARD class (targeted synthetic DMARD class) — University of Alabama at Birmingham. This targeted synthetic DMARD class drug works by selectively inhibiting a specific molecular target to modulate the immune response.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
targeted synthetic DMARD class TARGET	targeted synthetic DMARD class	University of Alabama at Birmingham	phase 3	Targeted synthetic DMARD	Unknown
SINECATECHINS	SINECATECHINS		marketed	Polyphenols	Unknown	2006-01-01
PODOFILOX	PODOFILOX		marketed	Topical antiviral	Unknown	1990-01-01
POLIDEXIDE SULFATE	POLIDEXIDE SULFATE		marketed	Unknown	Unknown	1974-01-01
SUTILAINS	SUTILAINS		marketed	Unknown	Unknown	1969-01-01
Pf-08032562	pf-08032562	Pfizer Inc.	marketed	unknown	unknown
Latanoprost plus adjunctive glaucoma medication	Latanoprost plus adjunctive glaucoma medication	Sight Sciences, Inc.	marketed	Prostaglandin analog with adjunctive glaucoma agent	FP prostaglandin receptor (latanoprost component); adjunctive target unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2026-10-02 — SINECATECHINS · 7858662 · Formulation · US

Sponsor landscape (Targeted synthetic DMARD class)

1. University of Alabama at Birmingham · 1 drug in this class